Skip to content
healthcare.dev

SAPHNELO

NDC 0310-3040, Anifrolumab-fnia, injection, solution, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-3040
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761123
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-3040 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANIFROLUMAB300 mg/2mL

Pharmacologic classes

Type I Interferon Receptor Antagonist [EPC]; Type I Interferon Receptor Antagonists [MoA]

Package NDCNDC-11Package
0310-3040-00003103040001 VIAL, GLASS in 1 CARTON (0310-3040-00) / 2 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d6203302-2128-41a7-b0b4-0e6c0704d4dc
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0310-3040

Use it

Look up 0310-3040 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-3040 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-3040. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.